z-logo
open-access-imgOpen Access
Sustained HIV RNA suppression after switching from enfuvirtide to etravirine in the early access programme
Author(s) -
Mona Loutfy,
Esteban Ribera,
Éric Florence,
Stéphane De Wit,
Antonella Castagna,
Robert J. Ryan,
Andrew Hill,
Hilde Vanaken,
Yvon van Delft,
Stephan Marks
Publication year - 2009
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkp366
Subject(s) - valaciclovir , aciclovir , medicine , etravirine , enfuvirtide , pharmacokinetics , penciclovir , pharmacology , human immunodeficiency virus (hiv) , virology , viral load , viral disease , herpesviridae , immunology , virus , antiretroviral therapy , herpes simplex virus , antigen , gp41 , epitope
SCOPUS: le.jinfo:eu-repo/semantics/publishe

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom